TipRanks
Go Ultimate55% OFF

Urogen Pharma (URGN) Hedge Fund Trading Activity

Trend: ▲ Hedge Funds Increased Holdings by 296.2K Shares Last Quarter

Hedge Fund Holdings in URGN

0.00$3.502.00M$15.254.00M$27.006.00M$38.758.00M$50.50Jul '24Jan '25Jul '25Jan '26Jul '26$32.72Stock PriceShares Held by Hedge Funds

Based on the 13F filings of 488 Hedge Funds tracked by TipRanks, as submitted to the SEC.

Hedge Fund Confidence Signal

Unlock Hedge Fund Confidence Signal

Hedge Fund Activity​

Activity
Star Ranking
Hedge fund activity
Hedge Fund ManagerStar RankingFirmActivityHolding ChangeValue Reported% of PortfolioFollow
BlackRock, Inc. hedge funds manager,  ,Rank BlackRock, Inc.Not Ranked Added12.51%$117,813,7650.02%
Michael Rockefeller hedge funds manager, Woodline Partners LP,Rank 381Michael RockefellerWoodline Partners LPNot Changed0.00%$18,426,7170.06%
Dennis J Purcell hedge funds manager, Aisling Capital Management LP,Rank 453Dennis J PurcellAisling Capital Management LPNot Changed0.00%$3,974,4000.84%
Cathie Wood hedge funds manager, ARK Investment Management LLC,Rank 347Cathie WoodARK Investment Management LLCReduced-12.15%$3,735,4940.02%
Robert L. Bender hedge funds manager, Robert Bender&Associates,Rank 27Robert L. BenderRobert Bender&AssociatesSold Out-100.00%$00.00%
Andrew J.M. Spokes hedge funds manager, Farallon Capital Management, L.L.C.,Rank 471Andrew J.M. SpokesFarallon Capital Management, L.L.C.Sold Out-100.00%$00.00%

FAQ

Which hedge funds hold Urogen Pharma?
The hedge funds that hold the most shares in Urogen Pharma are BlackRock, Inc., Dennis J Purcell and Andrew J.M. Spokes.
Are hedge funds buying or selling URGN?
In the last quarter hedge funds have Increased their holdings in Urogen Pharma by 296.2K shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in Urogen Pharma stock?
Warren Buffet currently does not own shares in Urogen Pharma.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here